1-Phenyl-3-(aminomethyl)pyrroles as Potential Antipsychotic Agents. Synthesis and Dopamine Receptor Binding

Journal of Medicinal Chemistry

Volumn 38, Issue 25, 1995, Pages 4950-4952

  Thurkauf, Andrew ^a   Yuan, Jun ^a   Chen, Xi ^a   Wasley, Jan W F ^a   Meade, Robin ^a   Woodruff, Kristine Harris ^a   Huston, Kevin ^a   Ross, Philip, C ^a  

^a NEUROGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [(1 PHENYL 3 PYRROLYL)METHYL] 4 (2 PYRIDYL)PIPERAZINE; ANILINE; DOPAMINE; DOPAMINE RECEPTOR; NEUROLEPTIC AGENT; PYRROLE DERIVATIVE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ARTICLE; CERCOPITHECIDAE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; NONHUMAN;

ANIMAL; ANTIPSYCHOTIC AGENTS; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; HUMAN; HYDROGEN BONDING; MAGNETIC RESONANCE SPECTROSCOPY; PYRROLES; RECEPTORS, DOPAMINE; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0028807149     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00025a013     Document Type: Article

References (13)

1. Andreasen, N. C. Negative Symptoms of Schizophrenia. Arch. Gen. Psychiatry 1982, 39, 784-788.
2. Andreasen, N. C.; Olsen, S. Negative vs. Positive Schizophrenia. Arch. Gen. Psychiatry 1982, 39, 789-794.
3. Lewine, R. R. J.; Rogg, L.; Meltzer, H. Y. Assessment of Negative and Positive Symptoms in Schizophrenia. Schizophrenia Bull. 1983, 9, 368-376.
4. Carlsson, A.; Lindquist, M. Effect of Chlorpromazine or Haloperidol on Formation of 3-Methoxytyramine and Normetanephrine in Mouse Brain. Acta Pharmacol. Toxicol. 1963, 20, 140-144.
5. Cook, L.; Tam, S. W.; Rohrbach, K. W. J. Pharmacol. Exp. Tker. 1992, 263, 1159-1166.
6. van Wijngaarden, I.; Kruse, C. G.; van der Heyden, J. A. M.; Tulp, M. M. 2-Phenylpyrroles as Conformationally Restricted Benzamide Analogues. A New Class of Potential Antipsychotics. 2. J. Med. Chem. 1988, 31, 1934-1940.
7. Hamdan, A.; Wasley, J. W. F. Synthesis of 1-Substituted Pyrrole-3-carboxaldehydes. Synthesis 1983, 13, 741-744.
8. Van Tol, H. H. M.; Buznow, J. R.; Guan, H. C.; Sunahara, R. K.; Seeman, P.; Niznik, H. B.; Civelli, O. Cloning of a Gene for a Human Dopamine D4 Receptor with High Affinity for the Antipsychotic Clozapine. Nature 1991, 350, 610-614.
9. Iwanami, S.; Takashima, M.; Hirata, Y.; Hasegawa, O.; Usuda, S. Synthesis and Neuroleptic Activity of the Benzamide cis-N-(1-Benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-meth-ylaminobenzamide and Related Compounds. J. Med. Chem. 1986, 29, 61-69.
10. Cheng, Y.; Prusoff, W. H. Relationship Between the Inhibition Constant (K,) and the concentration which causes 50 Per Cent Inhibition (IC50) of an Enzymatic Reaction. Biochem. Pharmacol. 1973, 22, 3099-3103.
11. 2 Receptor. J. Med. Chem. 1988, 31, 2027-2033.
12. 2 Receptors, Clozapine Occupies D4. Neuropsychopharmacology 1992, 7, 261-284.
13. Task Force on the Late Neurological Effects of Antipsychotic Drugs. Tardive Dyskinesia: Summary of a Task Force Report of the American Psychiatric Association. Am. J. Psychiatry 1980, 137, 1163-1172.